LTPA2020510I1
(en )
2020-07-10
Substituted 4-phenyl-pyridines for the treatment of NK-receptor related diseases
CY2019033I1
(en )
2019-11-27
MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF HYPERPLASTIC DISEASES
SMT201600254B
(en )
2016-08-31
PROCEDURE FOR THE PREPARATION OF HYDROMAGNITIS
BRPI1012116A2
(en )
2016-03-15
pharmaceutical composition for the treatment of heart disease
BRPI0908026A2
(en )
2015-07-21
Methods for the treatment of bowel diseases
BRPI0917567A2
(en )
2015-11-17
respiratory disease treatment
DK2477592T3
(en )
2013-10-28
walker WHEELCHAIR
ATE526024T1
(en )
2011-10-15
FLUVOXAMINE-AVOIDING PIRFENIDONE THERAPY
ZA201006752B
(en )
2011-05-25
Spiro-indole derivatives for the treatment of parasitic disease
BRPI0815551A2
(en )
2015-02-18
TREATMENT THROUGH HUCBC OF BETA-AMYLOID DISEASE
DK2627345T3
(en )
2014-09-01
TREATMENT FOR DISEASE DISEASES
BRPI0922653A2
(en )
2016-01-05
pharmaceutical preparation
GB0906159D0
(en )
2009-05-20
Drug combination for the treatment of proteostatic diseases
EE201300004A
(en )
2013-08-15
A combined pharmaceutical composition for the treatment of diseases or conditions of the cardiovascular system
DK2296651T3
(en )
2012-09-24
5-HYDROXYMETHYL-OXAZOLIDIN-2-ON DERIVATIVES FOR THE TREATMENT OF BACTERIAL INTESTINAL DISEASES
EP2544686A4
(en )
2013-06-26
Combination methods for treatment of disease
IT1395596B1
(en )
2012-10-16
PROCEDURE FOR THE PREPARATION OF SITAGLIPTIN
HK1170733A1
(en )
2013-03-08
Thioxanthene derivatives for the treatment of infectious diseases
BRPI0909764A2
(en )
2015-10-06
therapeutic compounds
BRPI0913939A2
(en )
2016-04-26
unit dose of apadenoson
BRPI0906879A2
(en )
2015-07-07
Therapeutic compounds
ES1070798Y
(en )
2010-01-22
COFFIN
BRPI1013544A2
(en )
2016-04-12
compounds with physiological effect
TH0901000513A
(en )
2016-06-03
Spirocyclic derivatives Amyd for the treatment of lung disease
IT1398273B1
(en )
2013-02-22
PROCEDURE FOR THE PREPARATION OF 14-BROMO DAUNOMICINA